[Federal Register Volume 65, Number 95 (Tuesday, May 16, 2000)]
[Notices]
[Page 31180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-12180]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Science Advisory Board to the National Center for Toxicological 
Research Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Science Advisory Board (the Board) to the 
National Center for Toxicological Research (NCTR).
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on June 5, 2000, 1 p.m. to 
4:30 p.m., and June 6, 2000, 8:30 a.m. to 1 p.m.
    Location: NCTR, Bldg. #12, Conference Center, Jefferson, AR.
    Contact Person: Ronald F. Coene, NCTR (HFT-10), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-6696, 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12559. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: The Board will be presented with draft reports on 
evaluations of NCTR's research programs in Endocrine Disrupter 
Knowledge Base, and Microbiology, for their review, discussion, and 
approval. The draft reports are the products of two site visit teams 
who conducted on site reviews over the last year. The staff from these 
programs will provide a preliminary response to the issues raised and 
recommendations made. Three progress reports will be presented to the 
Board on the recommendations it made at its last meeting, as a result 
of earlier site visits, on NCTR's programs in BioChem Toxicology, 
Genetic Toxicology and Molecular Epidemiology. The NCTR Acting Director 
will also provide a Center update and a discussion of future research 
directions.
    Procedure: On June 5, 2000, from 1 p.m. to 4:30 p.m., and June 6, 
2000, from 8:30 a.m. to 12 noon, the meeting is open to the public. 
Interested persons may present data, information, or views, orally or 
in writing, on issues pending before the committee. Written submissions 
may be made to the contact person by May 23, 2000. Oral presentations 
from the public will be scheduled between approximately 11 a.m. and 12 
noon on June 6, 2000. Time allotted for each presentation may be 
limited. Those desiring to make formal oral presentations should notify 
the contact person before May 23, 2000, and submit a brief statement of 
the general nature of the evidence or arguments they wish to present, 
the names and addresses of proposed participants, and an indication of 
the approximate time requested to make their presentation.
    Closed Committee Deliberations: On June 6, 2000, from 12 noon to 1 
p.m., the meeting will be closed to permit discussion where disclosure 
would constitute a clearly unwarranted invasion of personal privacy (5 
U.S.C. 552b(c)(6)). This portion of the meeting will be closed to 
permit discussion of information concerning individuals associated with 
the research programs at NCTR.
    The Commissioner of Food and Drugs approves the scheduling of 
meetings at locations outside the Washington, DC area on the basis of 
the criteria of 21 CFR 14.22 of FDA's regulations relating to public 
advisory committees.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: May 5, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-12180 Filed 5-15-00; 8:45 am]
BILLING CODE 4160-01-F